原发性肝癌患者行超声引导下经皮微波消融术后相关并发症的发生情况

李新慧; 冯志强; 张洪义; 吴迪; 赵刚; 汪鑫; 刘洋

doi:10.3969/j.issn.1001-5256.2016.01.011

原发性肝癌患者行超声引导下经皮微波消融术后相关并发症的发生情况

DOI: 10.3969/j.issn.1001-5256.2016.01.011

1. 安徽医科大学空军临床学院
2. 中国人民解放军空军总医院肝胆外科
3. 中国人民解放军空军总医院超声科

详细信息

中图分类号: R735.7
计量
- 文章访问数: 1913
- HTML全文浏览量: 32
- PDF下载量: 481
- 被引次数: 0
出版历程
- 收稿日期: 2015-10-09
- 出版日期: 2016-01-20

Severe complications after ultrasound-guided percutaneous microwave coagulation therapy for primary hepatic carcinoma

Clinical College of Air Force,Anhui Medical University

摘要

摘要:
目的探讨超声引导下原发性肝癌（PHC）经皮微波消融术（PMCT）相关严重并发症的原因及防治对策。方法选取2012年1月-2014年12月中国人民解放军空军总医院肝胆外科收治的PHC患者652例,均在超声引导下行PMCT。观察患者PMCT术后相关并发症的发生情况,并比较2012、2013和2014年并发症发生的差异,总结防治对策。计数资料组间比较采用χ2检验。结果共18例患者出现PMCT相关严重并发症,发生率为2.76%,其中包括腹腔出血10例,肝脓肿2例,肠瘘1例,膈肌破裂2例,急性肾衰竭1例,肿瘤种植转移1例,心脑血管疾病1例;因并发症死亡1例,并发症相关病死率为5.56%（1/18）;2012、2013和2014年PMCT相关并发症发生情况差异有统计学意义（χ2=11.78,P=0.003）。结论超声引导下PMCT总体上是安全的,但对于肝肿瘤部位特殊、肝硬化程度重、合并其他系统疾病者风险仍较大,严格掌握手术适应证,加强术前预防性治疗、术中规范性操作、术后严密观察患者病情变化能够显著降低PMCT并发症带来的不良后果。
- 肝肿瘤 /
- 导管消融术 /
- 手术后并发症
Abstract:
Objective To investigate the severe complications after ultrasound- guided percutaneous microwave coagulation therapy( PMCT) for primary hepatic carcinoma( PHC) and measures for prevention and treatment. Methods A total of 652 patients with PHC who were admitted to department of hepatobiliary surgery in Air Force General Hospital,PLA from January 2012 to December 2014 were selected,and ultrasound- guided PMCT was performed for all the patients. The occurrence of post- PMCT complications was observed and compared between the years 2012,2013,and 2014. Measures for prevention and treatment were summarized. The chi- square test was applied for comparison of categorical data between groups. Results A total of 18 patients experienced severe PMCT- related complications,with an incidence rate of 2. 76%. These complications included intra- abdominal hemorrhage( n = 10),liver abscess( n = 2),intestinal fistula( n = 1),diaphragmatic rupture( n = 2),acute renal failure( n = 1),tumor implantation metastasis( n = 1),and cardiovascular and cerebrovascular diseases( n = 1). One patient died of the complications above,and the complication- related mortality was 5. 56%( 1 /18). The incidence of PMCT- related complications showed a significant difference between 2012,2013,and 2014( χ2= 11. 78,P = 0. 003). Conclusion Ultrasound- guided PMCT is generally safe,but the patients with liver tumors in special sites,severe liver cirrhosis,and other systemic diseases still have a high risk. The indications for PMCT should be followed strictly,and enhancement in preoperative prophylactic treatment,standard intraoperative procedure,and careful postoperative observation can significantly reduce the adverse outcome caused by PMCT- related complications.
- liver neoplasms /
- catheter ablation /
- postoperative complications

HTML全文

参考文献(13)

[1]ZHANG HY,FENG ZQ.Establishment and implementation of“precise,sequential,and comprehensive”concepts in treatment of primary liver cancer[J].Chin J Med,2012,47(4):9-13.(in Chinese)张洪义,冯志强.“精准、序贯、综合”理念在原发性肝癌治疗中的构建实施[J].中国医刊,2012,47(4):9-13.

[2]SHIBATA T,IIMURO Y,YAMAMOTO Y,et al.Small hepatocellular carcinoma:comparison of radio-frequency ablation and percutaneous microwave coagulation therapy[J].Radiology,2002,223(2):331-337.

[3]STAHCZYK M,ZEGADLO A,ZWIEROWICZ T,et al.Microwave ablation of liver tumors as a new instrument for minimally invasive liver surgery[J].Pol Merkur Lekarski,2009,26(155):545-549.

[4]ZHANG HY,FENG ZQ.Minimally invasive treatment of liver cancer:dreams and realities of surgeons[J].Chin J Med,2015,50(2):1-2.(in Chinese)张洪义,冯志强.肝癌治疗微创化:外科医生的梦与非梦[J].中国医刊,2015,50(2):1-2.

[5]BO XW,ZHENG SG,XU HX,et al.Local therapeutic efficacy of Ultrasoundl-guided percutaneous bipolar radiofrequency ablation for liver cancer[J].Diagn Imag Interv,2014,23(3):258-262.(in Chinese)伯小皖,郑曙光,徐辉雄,等.超声引导经皮双极射频消融治疗肝癌的局部疗效观察[J].影像诊断与介入放射学,2014,23(3):258-262.

[6]KHAN NA,BAERLOCHER MO,OWEN RJ,et al.Ablative technologies in the management of patients with primary and secondary liver cancer:all overview[J].Can Assoc Radiol J,2010,61(4):217-222.

[7]XU JS,LI P,WANG ZG.Progresses in Ultrasound-guided percutaneous microwave ablation of hepatic malignancy[J].Chin J Interv,2014,11(9):621-624.(in Chinese)徐金顺,李攀,王志刚.超声引导下经皮微波消融治疗肝癌的研究进展[J].中国介入影像与治疗学,2014,11(9):621-624.

[8]RHIM H,YOON KH,LEE JM,et al.Major complications after radio-frequency thermal ablation of hepatic tumors:spectrum of imaging findings[J].Radiographics,2003,23(1):123-134.

[9]KANG TW,RHIM H,LEE MW,et al.Radiofrequency ablation for hepatocellular carcinoma abutting the diaphragm:comparison of effects of thermal protection and therapeutic efficacy[J].AJR Am J Roentgenol,2011,196(4):907-913.

[10]LI M,YU XL,LIANG P,et al.Percutaneous microwave ablation for liver cancer adjacent to the diaphragm[J].Int J Hyperthermia,2012,28(3):218-226.

[11]LIVRAGHI T,SOLBIATI L,MELONI MF,et al.Treatment of focal liver tumors with percutaneous radiofrequency ablation:complications encountered in a multicenter study[J].Radiology,2003,226(2):441-451.

[12]SHIMADA S,HIOTA M,BEPPU T,et al.A new procedure of percutaneous microwave coagulation therapy under artificial hydrothorax for patients with liver tumors in the hepatic dome[J].Surg Today,2001,31(1):40-44.

[13]LIU SJ,WANG ZG,YUAN XY,et al.Prevention and treatment for acute renal failure following radiofrequency ablation combined with ethanol injection for liver cancer[J].Sichuan J Cancer Control,2005,18(4):229-231.(in Chinese)刘树佳,王在国,袁湘瑜,等.肝癌射频消融联合无水酒精注射治疗后急性肾功能衰竭的防治[J].四川肿瘤防治,2005,18(4):229-231.

施引文献

资源附件(0)

访问统计